https://orcid.org/0000-0003-4681-888X
References
- Epstein J, Srigley J, Grignon D, et al., Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of prostate carcinoma. Hum Pathol. 2007;38(9):1305–1309.
- Netto GJ, Epstein JI. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol. 2006;30(9):1184–1188.
- Samaratunga H, Gardiner RA, Yaxley J, et al. Atypical prostatic glandular proliferation on needle biopsy. Annal Quant Cytol Histol. 2006; 28:104–110.
- Montironi R, Scattoni V, Mazzucchelli R, et al. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as “atypical small acinar proliferation suspicious for but not diagnostic of malignancy"). Eur Urol. 2006;50(4):666–674.
- Scattoni V, Roscigno M, Freschi M, et al. Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies. Urology. 2005;66(5):1043–1047.
- Iczkowski KA, Bassler TJ, Schwob VS, et al. Diagnosis of “suspicious for malignancy” in prostate biopsies: predictive value for cancer. Urology. 1998;51(5):749–758.
- Kim TS, Ko KJ, Shin SJS, et al. Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictors for cancer detection at a repeat biopsy. Korean J Urol. 2015;56(12):796–802.
- Nakai Y, Tanaka N, Miyake M, et al. Atypical small acinar proliferation and two or more cores of high-grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template-guided saturation biopsy aimed at sampling one core for each 1 ml of prostate volume. Res Rep Urol. 2017; 9:187–193.
- Schoenfield L, Jones JS, Zippe CD, et al. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int. 2007;99(4):770–774.
- Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24(8):819–832.
- Mancuso PA, Chabert C, Chin P, et al. Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferation. BJU Int. 2007;99(1):49–52.
- Leone A, Gershman B, Rotker K, et al. Atypical small acinar proliferation (ASAP): is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer Prostatic Dis. 2016;19(1):68–71.
- Wiener S, Haddock P, Cusano J, et al. Incidence of clinically significant prostate cancer after a diagnosis of atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, or benign tissue. Urology. 2017;110:161–165.
- Srirangam V, Rai BP, Abroaf A, et al. Atypical small acinar proliferation and high grade prostatic intraepithelial neoplasia: should we be concerned? An observational cohort study with a minimum follow-up of 3 years. Curr Urol. 2017;10(4):199–205.
- Van den Bergh RC, Roemeling S, Roobol MJ, et al. Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol. 2007;52(6):1560–1563.